Skip to content

Effect of Homoeopathy and CPT (Cognitive Processing Therapy) in Post Traumatic Stress Disorder

Management of Post traumatic stress disorder (PTSD) with homoeopathic intervention versus placebo along with CPT -A parallel arm randomized controlled exploratory study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042841
Enrollment
100
Registered
2022-05-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F431- Post-traumatic stress disorder (PTSD)

Interventions

Intervention1: Homoeopathic medicines: Homoeopathic medicines which shall be used in the trial are known pharmacopoeial preparations. Dosage of the medicine will be decided as per the status of case b

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Adults both male and female aged 18 to 65 years ii. Diagnosed case of PTSD in general population/COVID 19 patients/Contacts of patients/Health care workers/Frontline workers as per DSM -5 criteria with a minimum score of 31 on PCL-5 and 2 (moderate) and 3(severe) as per severity rating of CAPS- 5 iii. Willing to take Cognitive Processing Therapy (CPT) iv. Controlled cases of Hypothyroidism, hypertension andT2DM v. Written informed consent from the patient

Exclusion criteria

Exclusion criteria: i. Pregnant and lactating women ii. Any other pre-existing mental disorder iii. Presence of risk of suicide or self-destructive behaviours iv. Known cases of Tuberculosis, HIV, Cancer and any other

Design outcomes

Primary

MeasureTime frame
Primary Outcome measures: â?¢To compare the changes in severity of PTSD at baseline and monthly for 6 months using PCL-5 with LEC 5 and criteria A and CAPS Timepoint: Baseline, 1st, 2nd, 3rd, 4th, 5th and 6th month

Secondary

MeasureTime frame
Secondary Outcome measures: 1. To compare the changes in severity of PTSD at baseline, 1st, 2nd, 3rd, 4th, 5th and 6th month using PGA 2. To compare changes in Quality of life using WHOQoL-BREF at baseline, 3rd and 6th month Timepoint: 1.Baseline, 1st, 2nd, 3rd, 4th, 5th and 6th month 2.Baseline, 3rd and 6th month

Countries

India

Contacts

Public ContactAshish Mahajan

Central Research Institute of Homoeopathy

drnidhimahajan1@gmail.com9119124757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026